FDA Inspection 700465 — Protalix Ltd.
The FDA completed an inspection of Protalix Ltd. on Nov 11, 2010 in Karmi'El. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 11, 2010
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Karmi'El (Israel)
Additional details
Sponsor, Contract Research Organization